Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorVERGER, P.
dc.contributor.authorMMADI MRENDA, B.
dc.contributor.authorCORTAREDONA, S.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorDAUBECH-TOURNIER, Marie
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorVERDOUX, Helene
IDREF: 115951903
dc.date.accessioned2021-01-06T11:30:19Z
dc.date.available2021-01-06T11:30:19Z
dc.date.issued2018-04
dc.identifier.issn1600-0447 (Electronic) 0001-690X (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/23703
dc.description.abstractEnOBJECTIVE: To identify temporal trajectories of anxiolytic benzodiazepine (A-BZD) use over 10 years among new A-BZD users aged 50 and older and describe treatment patterns and demographic and clinical characteristics associated with each trajectory. METHOD: A representative cohort of the French national health insurance fund users was tracked from 2006 through 2015. We used latent class mixed models to identify the trajectories. RESULTS: We observed four trajectories among new users (no A-BZD dispensing in 2005) plus one non-use trajectory. The proportion of occasional use among users was 60%; early increasing use, 10%; late increasing use, 17%; and increasing/decreasing use, 13%. Prevalence of occasional use decreased with age in women, but not men. Duration of treatment episodes and doses differed between trajectories. Multiple regression analyses with occasional use as the reference showed that the other three trajectories shared characteristics (age, coprescriptions of other psychotropic drugs, and more general practitioner consultations) but differed by the presence at inclusion or occurrence during follow-up of psychiatric, neurodegenerative, and somatic conditions. CONCLUSION: We found four different long-term temporal trajectories in new A-BZD users (occasional, early increasing, late increasing, and increasing/decreasing use). Difficulties quitting or reducing consumption may be very different for each trajectory, requiring tailored care approaches.
dc.language.isoENen_US
dc.subject.enPharmacoEpi-Drugs
dc.title.enTrajectory analysis of anxiolytic dispensing over 10 years among new users aged 50 and older
dc.title.alternativeActa Psychiatr Scanden_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1111/acps.12858en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed29441519en_US
bordeaux.journalActa psychiatrica Scandinavicaen_US
bordeaux.page328-341en_US
bordeaux.volume137en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue4en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.teamPharmacoEpi-Drugsen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.exportfalse
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Acta%20psychiatrica%20Scandinavica&rft.date=2018-04&rft.volume=137&rft.issue=4&rft.spage=328-341&rft.epage=328-341&rft.eissn=1600-0447%20(Electronic)%200001-690X%20(Linking)&rft.issn=1600-0447%20(Electronic)%200001-690X%20(Linking)&rft.au=VERGER,%20P.&MMADI%20MRENDA,%20B.&CORTAREDONA,%20S.&DAUBECH-TOURNIER,%20Marie&VERDOUX,%20Helene&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée